Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Gastric
Study Phase
Phase 3
Study Completion Date
1999
NCT00290966Uploaded 08-18-2015
Available for Download
PDS UID: Gastric_SanofiU_1999_143
Open Label, Randomized Multicentre Phase II/III Study of Docetaxel in Combination With Cisplatin (CDDP) or Docetaxel in Combination With 5-Fluorouracil (5-FU) and CDDP Compared to the Combination of CDDP and 5-FU in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease
PDS UID: Gastric_Multipl_1999_416Go to Study
Enhancing the Analytic Capacity of Gastric_SanofiU_1999_143 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLSANOFI_XRP6976_TAX325_Clinical_Study_Protocol_Redacted.pdf
CRFSANOFI_XRP6976_TAX325_CRF.pdf
DATA DICTIONARYsanofi_XRP6976_TAX325_data_definition.xls
DATA (COMPARATOR ARM)sanofi_xrp6976_tax325_datasets_and_readme.zip